v3.25.3
Share-Based Payments - Share-Based Compensation Expense by Share-Based Compensation Program (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 02, 2024
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Summary of share based compensation expense associated with different programs [Abstract]          
Subtotal   $ 78.4 $ 131.1 $ 240.6 $ 275.4
Capitalized share-based compensation costs   (3.1) (2.4) (9.4) (8.0)
Share-based compensation expense included in total cost and expense   75.3 128.7 231.2 267.4
Human Immunology Biosciences          
Summary of share based compensation expense associated with different programs [Abstract]          
Share-based compensation expense $ 56.4 0.0 56.4 0.0 56.4
Time-vested restricted stock units          
Summary of share based compensation expense associated with different programs [Abstract]          
Share-based compensation expense   60.1 59.1 186.8 174.7
Performance stock units settled in stock          
Summary of share based compensation expense associated with different programs [Abstract]          
Share-based compensation expense   15.5 13.0 44.1 35.2
Employee stock purchase plan          
Summary of share based compensation expense associated with different programs [Abstract]          
Share-based compensation expense   1.8 1.9 6.9 8.2
Performance stock units settled in cash          
Summary of share based compensation expense associated with different programs [Abstract]          
Share-based compensation expense   0.0 (0.5) 0.0 (2.5)
Stock options          
Summary of share based compensation expense associated with different programs [Abstract]          
Share-based compensation expense   1.0 1.0 2.8 2.8
Market stock units          
Summary of share based compensation expense associated with different programs [Abstract]          
Share-based compensation expense   $ 0.0 $ 0.2 $ 0.0 $ 0.6